CO6741224A2 - Formas cristalinas de un ácido alcoxiimidazol-1-ilmetil bifenil carboxílico - Google Patents
Formas cristalinas de un ácido alcoxiimidazol-1-ilmetil bifenil carboxílicoInfo
- Publication number
- CO6741224A2 CO6741224A2 CO13111802A CO13111802A CO6741224A2 CO 6741224 A2 CO6741224 A2 CO 6741224A2 CO 13111802 A CO13111802 A CO 13111802A CO 13111802 A CO13111802 A CO 13111802A CO 6741224 A2 CO6741224 A2 CO 6741224A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkoxyimidazol
- carboxylic acid
- crystalline forms
- biphenyl carboxylic
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formas de sal cristalina de ácido 4-{2-etoxi-4-etil-5-[((S)-2-mercapto-4-metilpentanoilamino)metil]imidazol-1-ilmetil}-3-fluoro bifenil-2-carboxílico. La presente invención también proporciona composiciones farmacéuticas que comprenden los compuestos cristalinos, procesos e intermediarios para preparar los compuestos cristalinos, y métodos para usar los compuestos cristalinos para tratar enfermedades tales como la hipertensión.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41201110P | 2010-11-10 | 2010-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6741224A2 true CO6741224A2 (es) | 2013-08-30 |
Family
ID=45003086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13111802A CO6741224A2 (es) | 2010-11-10 | 2013-05-03 | Formas cristalinas de un ácido alcoxiimidazol-1-ilmetil bifenil carboxílico |
Country Status (19)
Country | Link |
---|---|
US (3) | US8362060B2 (es) |
EP (1) | EP2638017B1 (es) |
JP (2) | JP2013542258A (es) |
KR (1) | KR20130130730A (es) |
CN (1) | CN103189362B (es) |
AR (1) | AR083828A1 (es) |
AU (1) | AU2011326622B2 (es) |
BR (1) | BR112013011715A2 (es) |
CA (1) | CA2812598A1 (es) |
CO (1) | CO6741224A2 (es) |
ES (1) | ES2567721T3 (es) |
HK (1) | HK1187919A1 (es) |
IL (1) | IL225303A0 (es) |
MX (1) | MX2013005165A (es) |
NZ (1) | NZ609804A (es) |
RU (1) | RU2013126403A (es) |
SG (1) | SG189448A1 (es) |
TW (1) | TW201300366A (es) |
WO (1) | WO2012064807A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI448284B (zh) | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
CN106810542B (zh) * | 2015-11-30 | 2021-03-09 | 苏州开拓药业股份有限公司 | 一种硫代咪唑烷酮化合物的晶型、盐型及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006027680A1 (en) | 2004-09-10 | 2006-03-16 | Pfizer Limited | 3-(1-carbamoylcyclohexyl) propionic acid derivatives as inhibitors of neutral endopeptidase enzyme |
AR057882A1 (es) | 2005-11-09 | 2007-12-26 | Novartis Ag | Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra |
WO2007106708A2 (en) | 2006-03-10 | 2007-09-20 | Novartis Ag | Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril |
TWI448284B (zh) | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
TW201014830A (en) * | 2008-09-30 | 2010-04-16 | Theravance Inc | Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
TWI545114B (zh) * | 2009-09-29 | 2016-08-11 | 施萬生物製藥研發Ip有限責任公司 | 製備聯苯基咪唑化合物之方法 |
WO2011109579A1 (en) * | 2010-03-04 | 2011-09-09 | Theravance, Inc. | Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
-
2011
- 2011-11-09 KR KR1020137014134A patent/KR20130130730A/ko not_active Application Discontinuation
- 2011-11-09 JP JP2013538839A patent/JP2013542258A/ja active Pending
- 2011-11-09 US US13/292,370 patent/US8362060B2/en active Active
- 2011-11-09 MX MX2013005165A patent/MX2013005165A/es unknown
- 2011-11-09 AU AU2011326622A patent/AU2011326622B2/en not_active Ceased
- 2011-11-09 SG SG2013029178A patent/SG189448A1/en unknown
- 2011-11-09 EP EP11785872.0A patent/EP2638017B1/en active Active
- 2011-11-09 CA CA2812598A patent/CA2812598A1/en not_active Abandoned
- 2011-11-09 BR BR112013011715A patent/BR112013011715A2/pt not_active IP Right Cessation
- 2011-11-09 ES ES11785872.0T patent/ES2567721T3/es active Active
- 2011-11-09 CN CN201180053069.5A patent/CN103189362B/zh not_active Expired - Fee Related
- 2011-11-09 WO PCT/US2011/059895 patent/WO2012064807A1/en active Application Filing
- 2011-11-09 RU RU2013126403/04A patent/RU2013126403A/ru not_active Application Discontinuation
- 2011-11-09 NZ NZ609804A patent/NZ609804A/en not_active IP Right Cessation
- 2011-11-10 TW TW100141108A patent/TW201300366A/zh unknown
- 2011-11-10 AR ARP110104201A patent/AR083828A1/es unknown
-
2012
- 2012-12-19 US US13/720,395 patent/US8802709B2/en not_active Expired - Fee Related
-
2013
- 2013-03-18 IL IL225303A patent/IL225303A0/en unknown
- 2013-05-03 CO CO13111802A patent/CO6741224A2/es unknown
-
2014
- 2014-02-04 HK HK14101073.2A patent/HK1187919A1/zh not_active IP Right Cessation
- 2014-06-27 US US14/317,060 patent/US9249105B2/en not_active Expired - Fee Related
-
2015
- 2015-09-04 JP JP2015174397A patent/JP2016028061A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US8362060B2 (en) | 2013-01-29 |
US20120115920A1 (en) | 2012-05-10 |
EP2638017A1 (en) | 2013-09-18 |
BR112013011715A2 (pt) | 2017-10-31 |
AU2011326622A1 (en) | 2013-04-04 |
AR083828A1 (es) | 2013-03-27 |
US9249105B2 (en) | 2016-02-02 |
US20150133518A1 (en) | 2015-05-14 |
MX2013005165A (es) | 2013-07-05 |
HK1187919A1 (zh) | 2014-04-17 |
ES2567721T3 (es) | 2016-04-26 |
EP2638017B1 (en) | 2016-01-27 |
US20130267573A1 (en) | 2013-10-10 |
JP2013542258A (ja) | 2013-11-21 |
AU2011326622B2 (en) | 2014-12-18 |
RU2013126403A (ru) | 2014-12-20 |
IL225303A0 (en) | 2013-06-27 |
CN103189362A (zh) | 2013-07-03 |
KR20130130730A (ko) | 2013-12-02 |
SG189448A1 (en) | 2013-05-31 |
NZ609804A (en) | 2015-02-27 |
CA2812598A1 (en) | 2012-05-18 |
TW201300366A (zh) | 2013-01-01 |
CN103189362B (zh) | 2015-03-11 |
US8802709B2 (en) | 2014-08-12 |
WO2012064807A1 (en) | 2012-05-18 |
JP2016028061A (ja) | 2016-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1116987T1 (el) | Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις | |
CR20140554A (es) | Compuestos de acido dimetil-benzoico | |
UY33314A (es) | Derivados de acido 1-amino-2-ciclopropiletilboronico | |
ECSP11011517A (es) | Compuestos antivirales | |
EA201590868A1 (ru) | Противовирусные соединения | |
GT201500051A (es) | Inhibidores de glucosilceramida sintasa | |
UY33735A (es) | Compuestos antivirales | |
GT201400034A (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
GT201300215A (es) | Inhibidores de glucosilceramida sintasa | |
EA201790963A1 (ru) | Противовирусные соединения | |
EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
UY31770A1 (es) | Inhibidores de catepsina c | |
EA201490567A1 (ru) | Новые бициклические производные дигидрохинолин-2-она | |
EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
UA113062C2 (xx) | Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону | |
EA201491149A1 (ru) | Пиразолопиридиновые производные, способы их получения и их терапевтическое применение | |
EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
CR20160072A (es) | Compuestos y composiciones como inhibidores de la mek | |
TN2015000261A1 (fr) | Dérivés d'imidazopyridazine servant de modulateurs des recepteurs gabaa | |
EA201690844A1 (ru) | Ингибиторы gsk-3 | |
EA201400165A1 (ru) | Частицы на основе полиакрилата, которые содержат активное соединение | |
CO6660462A2 (es) | Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos | |
CO6761373A2 (es) | Derivados de ácido 3-heteroaroilamino-propiónico sustituidos y su uso como sustancias farmacéuticas | |
WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases |